About: Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 April 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'abril de 2020 (ast) scientific article published on 17 April 2020 (en) наукова стаття, опублікована 17 квітня 2020 (uk)
publication date	wds:Q92013315-57FFBD87-AB29-4F35-AF27-29134BB18C46
publication date	2020-04-17 00:00:00Z (xsd:dateTime)
author name string	wds:Q92013315-3B40D4F3-D86D-4EF5-AF70-A7653BF52165 wds:Q92013315-499100F7-B36B-4828-8DE9-79B8E3E524CF wds:Q92013315-707EC182-9292-4138-A4D6-6203B11192C6 wds:Q92013315-922F99D1-219A-4683-A9F4-7AE239F93540 wds:Q92013315-C8C95D46-5368-4F50-89B8-93A25B1AAE7E
author name string	Rune Hartmann Thomas R O'Brien Ludmila Prokunina-Olsson Raymond P Donnelly Sarah S Jackson
rdfs:label	Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (en) Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (nl)
skos:prefLabel	Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (en) Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (nl)
name	Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (en) Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (nl)
author	wds:Q92013315-F82D1BB5-9060-4871-9BF5-13937CEDD0BE
author	David L Thomas
title	wds:Q92013315-8B48A8EE-6BDB-4609-BC5E-7DAA3CE0C8DD
title	Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 (en)
instance of	wds:Q92013315-E6B8AEFC-C81E-4CC9-8EAE-A81AA4C9764B wds:Q92013315-c6241981-c5d5-4a37-b8f4-995fa8bc3b49
instance of	editorial scholarly article
main subject	wds:Q92013315-6237F6CB-5F30-415B-8175-C0D0A359376D wds:Q92013315-AFDD5948-9AC0-4B70-A3A6-9A2CEAAC0157
main subject	SARS-CoV-2 COVID-19 mortality
PubMed ID	wds:Q92013315-98B4A9F2-AB82-4A32-B556-BF00190E4162
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32301957
PubMed ID	32301957
published in	wds:Q92013315-4C325F9C-0224-4A22-B3A8-7C6DBB10B544
published in	Clinical Infectious Diseases
DOI	wds:Q92013315-544A1C33-7A29-4D09-BA41-DCB688C78C2F
DOI	http://dx.doi.org/10.1093/CID/CIAA453
DOI	10.1093/CID/CIAA453
Dimensions Publication ID	wds:Q92013315-2B165F25-A8A1-44D7-863D-1AC96516D2D4
Dimensions Publication ID	1126726362
PMCID	wds:Q92013315-01063AE0-A4DA-4613-91A0-2006115CF217
PMCID	7184357
COVIDWHO ID	wds:Q92013315-AE8C14F2-DC27-4487-A69D-112DCF3AA9A0
COVIDWHO ID	covidwho-72338
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q92013315
is cites work of	Interplay between SARS-CoV-2 and the type I interferon response Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis Interferon beta-1b for COVID-19 Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions Single-cell landscape of immunological responses in patients with COVID-19 Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor SARS-CoV-2 infection in India bucks the trend: Trained innate immunity? Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19? SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways SARS-CoV-2 infection induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) Protein Inhibits Type I and III Interferon Production by Targeting RIG-I/MDA-5 Signaling SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection Immune Response and COVID-19: A mirror image of Sepsis
is cites work of	wds:Q98161951-A0C6FE9F-A714-4362-94FA-CD9F8B736F12 wds:Q97645890-3F064590-048C-45E2-AEBE-B27BE462CC9F wds:Q96953625-5ADB2BE9-3E3F-4C87-932D-8B3285E3420B wds:Q95275857-C8D300C0-8673-4C96-9D08-AC053B0A49E1 wds:Q98578449-43D08AF2-1805-448D-8FE6-C654F07FCD6A wds:Q106624678-0CEDBFE3-C503-4ECF-A73B-1C4A6AC8F5A8 wds:Q94657373-0374913C-432A-45E4-A7D0-09F82D7E140A wds:Q98394889-B1F426D6-C39E-4F43-9542-DF04849FB812 wds:Q108685045-AD7AD36C-5C1D-447B-929A-8CDBFE89BE6C wds:Q100737229-BDF898D6-1757-43AD-A00D-C6109B7CE7AD wds:Q106452240-E39C4322-4B6F-446B-A22B-640C392B94C7 wds:Q99612881-84FB809E-F123-4674-B9EA-BF9BD81E8F4C wds:Q104437401-EC66656A-A424-4A78-BDF4-EF84E32CD751 wds:Q98775560-DC74A37E-5286-4F25-A2D3-172AF0EB84FA wds:Q104437642-92BF8E76-1D43-4168-B160-C7A1EC5E952D wds:Q98464576-8F43DC18-9B15-4A30-86E7-1C92B3F86CF9

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software